Efficacies of albendazole sulfoxide and albendazole sulfone against in vitro-cultivated Echinococcus multilocularis metacestodes

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 5, 1999, Pages 1052-1061

  Ingold, Katrin ^a   Bigler, Peter ^a   Thormann, Wolfgang ^a   Cavaliero, Tania ^b   Gottstein, Bruno ^a   Hemphill, Andrew ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE SULFONE; ALBENDAZOLE SULFOXIDE; BENZIMIDAZOLE; MEBENDAZOLE;

ARTICLE; DRUG EFFICACY; DRUG UPTAKE; ECHINOCOCCUS MULTILOCULARIS; IN VITRO STUDY; LIVER HYDATID CYST; LUNG HYDATID CYST; NONHUMAN; PARASITE IDENTIFICATION; PRIORITY JOURNAL; RECURRENCE RISK;

EID: 0032930607     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.5.1052     Document Type: Article

References (45)

1. Ammann, R. W., R. Hirsbrunner, J. Cotting, U. Steiger, P. Jacquier, and J. Eckert. 1990. Recurrence rate after discontinuation of long-term mebendazole therapy in alveolar echinococcosis (preliminary results). Am. J. Trop. Med. Hyg. 43:506-515.
2. Ammann, R. W., N. Ilitsch, B. Marincek, and A. U. Freiburghaus. 1994. Effect of chemotherapy on the larval mass and the long-term course of alveolar echinococcosis. Hepatology 19:735-742.
3. Ammann, R. W., and Swiss Echinococcosis Study Group. 1991. Improvement of liver resectional therapy by adjuvant chemotherapy in alveolar hydatid disease. Parasitol. Res. 77:290-293.
4. Barret, J. 1997. Biochemical pathways in parasites, p. 1-31. In M. Rogan (ed.), Analytical parasitology. Springer Verlag, Heidelberg, Germany.
5. 13C nuclear magnetic resonance. Int. J. Parasitol. 17:1333-1341.
6. 1H-nuclear magnetic resonance study of three species of Hymenolepis adults. Parasitol. Res. 79: 334-336.
7. 6 glucose. Exp. Parasitol. 62:231-238.
8. Casado, N., J. Perez-Serrano, G. Denegri, and F. Rodriguez-Caabeiro. 1994. Development of truncated microtriches in Echinococcus granulosus protoscolices. Parasitol. Res. 80:355-357.
9. Casado, N., J. Perrez-Serrano, G. Denegri, and F. Rodriguez-Caabeiro. 1996. Development of a chemotherapeutic model for the in vitro screening of drugs against Echinococcus granulosus cysts: the effects of an albendazole-albendazolesulphoxide combination. Int. J. Parasitol. 26:59-65.
10. Chinnery, J. B., and D. L. Morris. 1986. Effect of albendazolesulphoxide on viability of hydatid protoscoleces in vitro. Trans. R. Soc. Trop. Med. Hyg. 80:815-817.
11. Delabre, I., C. Gabrion, F. Contant, A.-F. Petavy, and S. Deblock. 1987. The susceptibility of the mongolian gerbil (Meriones unguiculatus) and the OFa mouse strain to Echinococcus multilocularis - ultrastructural aspects of the cysts. Int. J. Parasitol. 17:773-780.
12. Eckert, J. 1986. Prospects for treatment of the metacestode stage of Echinococcus, p. 250-284. In R. C. A. Thompson (ed.), The biology of Echinococcus and hydatid disease. Allen & Unwin, London, United Kingdom.
13. Garcia-Llamazares, J. L., A. I. Alvarez-de-Felipe, P. A. Redondo-Cardena, and J. G. Prieto-Fernandez. 1998. Echinococcus granulosus: membrane permeability of secondary hydatid cysts to albendazolesulfoxide. Parasitol. Res. 84:417-420.
14. Gil-Grande, L. A., F. Rodriguez-Caabeiro, J. G. Prieto, J. J. Sanchez-Ruano, C. Brasa, L. Agullar, F. Garcia-Hoz, N. Casada, R. Barcena, and A. I. Alvarez. 1993. Randomized controlled trial of efficacy of albendazole in intra-abdominal hydatid disease. Lancet 342:1269-1272.
15. Gottstein, B. 1992. Echinococcus multilocularis infection: immunology and immunodiagnosis. Adv. Parasitol. 31:321-379.
16. Heath, D. D., M. J. Christie, and R. A. F. Chevis. 1975. The lethal effect of mebendazole on secondary Echinococcus granulosus cysticerci and Taenia pisiformis and tetrahydria of Mesocestoides corti. Parasitology 70:273-285.
17. Hemphill, A., and B. Gottstein. 1995. Immunological and morphological studies on the proliferation of in vitro cultivated Echinococcus multilocularis metacestode. Parasitol. Res. 81:605-614.
18. Hemphill, A., and B. Gottstein. 1996. In vitro cultivation and proliferation of Echinococcus multilocularis metacestode, p. 79-84. In 3. Urchino and N. Sato (ed.), Alveolar echinococcosis, strategy for eradication of alveolar echinococcosis of the liver. Fuji Shoin, Sapporo, Japan.
19. Hemphill, A., and S. L. Croft. 1997. Electron microscopy in parasitology, p. 227-268. In M. Rogan (ed.), Analytical parasitology. Springer Verlag, Heidelberg, Germany.
20. Horten, R. J, 1989. Chemotherapy of Echinococcus infection in man with albendazole. Trans. R. Soc. Trop. Med. Hyg. 83:97-102.
21. Ingold, K., B. Gottstein, and A. Hemphill. 1998. Identification of a novel laminated layer-associated protein in Echinococcus multilocularis metacestodes. Parasitology 116:363-372.
22. Jura, H., A. Bader, and M. Frosch. 1998. In vitro activities against Echinococcus multilocularis metacestodes. Antimicrob. Agents Chemother. 42:1052-1056.
23. Kern, P., J. G. Wechsler, W. Lauchart, and R. Kunz. 1994. Klinik und Therapie der alveolären Echinokokkose. Deutsches Aerzteblatt-Aerztliche Mitteilungen 91:B1857-B1863.
24. Lacey, E. 1990. Mode of action of benzimidazoles. Parasitol. Today 6:112-115.
25. Lawton, P., A. Hemphill, P. Deplazes, B. Gottstein, and M. E. Sarciron. 1997. Echinococcus multilocularis metacestodes: immunological and immunocytochemical analysis of the relationships between alkaline phosphatase and the Em2 antigen. Exp. Parasitol. 87:142-149.
26. Löscher, T., F. von Sonnenburg, and H. D. Nothdurft. 1992. Epidemiology and therapy of human echinococcosis in central Europe. 8th International Congress for Tropical Medicine and Malaria.
27. Mesarini-Wicki, B. 1991. Long-term course of alveolar echinococcosis in 70 patients treated by benzimidazol derivates (mebendazole and albendazole) (1976-1989). Inaugural dissertation. Universitätsspital Zürich, Zürich, Switzerland.
28. Morris, D. L., J. B. Chinnery, G. Georgiou, G. Stamatakis, and B. Golematis. 1987. Penetration of albendazolesulphoxide into hydatid cysts. Gut 28:75-80.
29. 1H-nuclear magnetic resonance spectroscopy. Parasitol. Res. 78:665.
30. Perez-Serrano, J., G. Denegri, N. Casado, G. Bodega, and F. Rodriguez-Caabeiro. 1995. Anti-tubulin immunohistochemistry study of Echinococcus granulosus protoscolices incubated with albendazole and albendazolesulphoxide in vitro. Parasitol. Res. 81:438-440.
31. Rausch, R. L., J. F. Wilson, P. M. Schantz, and B. J. McMahon. 1987. Spontaneous death of Echinococcus multilocularis: cases diagnosed by Em2 ELISA and clinical significance. Am. J. Trop. Med. Hyg. 36:576-585.
32. Richards, K. S., C. Arme, and J. F. Bridges. 1984. Echinococcus granulosus equinus: variation in the germinal layer of murine hydatids and evidence of autophagy. Parasitology 89:35-37.
33. Richards, K. S., D. L. Morris, and D. H. Taylor. 1989. Echinococcus multilocularis: ultrastructural effect of in vivo albendazole and praziquantel therapy, singly and in combination. Ann Trop. Med. Parasitol. 83:479-484.
34. Richards, K. S., and D. L. Morris. 1990. Effect of albendazole on human hydatid cysts: an ultrastruclural study. HPB. Surg. 2:105-112.
35. Rodriguez, J. M., C. Bories, I. Emery, H. Fessi, J. P. Derissaguet, and M. Liance. 1995. Development of an injectable formulation of albendazole and in vivo evaluation of its efficacy against Echinococcus multilocularis metacestode. Int. J. Parasitol. 12:1437-1441.
36. Sarciron, M. E., N. Walchshofer, S. Walbaum, C. Arsac, J. Descotes, A.-F. Petavy, and J. Paris. 1997. Increases in the effects of albendazole on Echinococcus multilocularis metacestodes by the dipeptide methyl ester (Phe-Phe-OMe). Am. J. Trop. Med. Hyg. 56:226-230.
37. Schantz, P. M., F. H. Brandt, C. M. Dickinson, C. R. Allen, J. M. Robert, and M. L. Eberhard. 1996. Effects of albendazole on Echinococcus multilocularis infection in the Mongolian jird. J. Infect. Dis. 162:1403-1407.
38. Siles-Lucas, M., R. Felleisen, A. Hemphill, W. Wilson, and B. Gottstein. Stage-specific expression of Echinococcus multilocularis protein 14-3-3. Mol. Biochem. Parasitol. 91:281-293.
39. Smyth, J. D., A. B. Howkins, and M. Barton. 1966. Factors controlling the differentiation of the hydatid organism, Echinococcus granulosus, into cystic or strobilar stages in vitro. Nature 211:1374-1377.
40. Smyth, J. D., and D. P. McManus. 1989. The physiology and biochemistry of cestodes. Cambridge University Press, Cambridge, United Kingdom.
41. Taylor, D. H., D. L. Morris, D. Reffin, and K. S. Richards. 1989. Comparison of albendazole, mebendazole and praziquantel chemotherapy of Echinococcus multilocularis in a gerbil model. Gut 30:1401-1405.
42. Van den Bossche, H. 1986. Mode of action of anticestodal agents, p. 139-157. In W. C. Campbell and R. S. Rew (ed.), Chemotherapy of parasitic diseases. Plenum Press, New York, N.Y.
43. Wen, H., R R. New, M. Muhmut, J. H. Wang, Y. H. Wang, J. H. Zhang, Y. M. Shao, and P. S. Craig. 1996. Pharmacology and efficacy of liposome-entrapped albendazole in experimental secondary alveolar echinococcosis and effect of co-administration with cimetidine. Parasitology 113:111-121.
44. Wilson, J. F., R. L. Rausch, B. J. McMahon, and P. M. Schantz. 1992. Parasitocidal effect of chemotherapy in alveolar hydatid disease: a review of experience with mebendazole and albendazole in Alaskan Eskimos. Clin. Infect. Dis. 15:234-249.
45. Zeugin, T., T. Zysset, and J. Cotting. 1990. Therapeutic monitoring of albendazole: a high performance liquide chromatography method for determination of its active metabolite albendazole sulfoxide. Ther. Drug Monit. 12:187-190.